About Bios
Bios is a company based in Cambridge (United Kingdom) founded in 2015 by Oliver Armitage and Emil Hewage.. Bios has raised $26.02 million across 6 funding rounds from investors including Gov.uk, NIH and Cisco Investments. The company has 25 employees as of December 31, 2023. Bios offers products and services including Neural Interface, AI Platform, Autonomic Therapy Initiative, and Neural Dosing Platform. Bios operates in a competitive market with competitors including Neuralink, Combinostics, Paradromics, Inner Cosmos and Neurobrave, among others.
- Headquarter Cambridge, United Kingdom
- Employees 25 as on 31 Dec, 2023
- Founders Oliver Armitage, Emil Hewage
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bios Health Ltd
- Date of Incorporation 05 May, 2015
- Jurisdiction CAMBRIDGE, UNITED KINGDOM
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$26.02 M (USD)
in 6 rounds
-
Latest Funding Round
$20 M (USD), Series A
Jun 22, 2023
-
Investors
Gov.uk
& 15 more
-
Employee Count
25
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bios
Bios offers a comprehensive portfolio of products and services, including Neural Interface, AI Platform, Autonomic Therapy Initiative, and Neural Dosing Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for reading and writing neural data in real-time.
Analyzes neural biomarkers for disease insights and treatments.
Focuses on neural therapies for cardiovascular diseases.
Personalizes therapies using AI for nervous system feedback.
Unlock access to complete
Unlock access to complete
Funding Insights of Bios
Bios has successfully raised a total of $26.02M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $20 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series A — $20.0M
-
First Round
First Round
(01 Jun 2017)
- Investors Count 16
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2023 | Amount | Series A - Bios | Valuation | Selvedge Venture , XTX Markets | |
| Jul, 2022 | Amount | Seed - Bios | Valuation | MEDTEQ |
|
| Jun, 2022 | Amount | Grant - Bios | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Bios
Bios has secured backing from 16 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Gov.uk, NIH and Cisco Investments. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are focused on healthcare startups addressing age-related conditions.
|
Founded Year | Domain | Location | |
|
Early-stage venture capital is provided to Canadian technology startups by Real Ventures.
|
Founded Year | Domain | Location | |
|
Early-stage startups are accelerated via funding and educational programs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bios
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Bios
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bios Comparisons
Competitors of Bios
Bios operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neuralink, Combinostics, Paradromics, Inner Cosmos and Neurobrave, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Implantable brain-computer interfaces are developed for thought-based device control.
|
|
| domain | founded_year | HQ Location |
AI-powered solutions for neurological disorder detection and management are developed.
|
|
| domain | founded_year | HQ Location |
Data streaming brain-computer interfaces for neural connections are provided.
|
|
| domain | founded_year | HQ Location |
AI-based implantable device for mood and addiction treatment is provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based neurology disease detection tool for healthcare professionals
|
|
| domain | founded_year | HQ Location |
Actionable insights for neurological conditions are generated via AI platform.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bios
Frequently Asked Questions about Bios
When was Bios founded?
Bios was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is Bios located?
Bios is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Who is the current CEO of Bios?
Emil Hewage is the current CEO of Bios. They have also founded this company.
Is Bios a funded company?
Bios is a funded company, having raised a total of $26.02M across 6 funding rounds to date. The company's 1st funding round was a Grant of $100K, raised on Jun 01, 2017.
How many employees does Bios have?
As of Dec 31, 2023, the latest employee count at Bios is 25.
What does Bios do?
BIOS was founded in 2015 in Cambridge, United Kingdom, within the neurotechnology sector. Neural interfaces and AI tools are developed to measure and analyze neural data in real time. A platform is provided for processing such data, alongside programming languages designed for the nervous system. Insights into diseases are enabled, supporting the development of new treatments. Therapies are personalized through neural recordings and AI applications.
Who are the top competitors of Bios?
Bios's top competitors include Neuralink, Paradromics and Combinostics.
What products or services does Bios offer?
Bios offers Neural Interface, AI Platform, Autonomic Therapy Initiative, and Neural Dosing Platform.
Who are Bios's investors?
Bios has 16 investors. Key investors include Gov.uk, NIH, Cisco Investments, Selvedge Venture, and XTX Markets.